Pfizer vaccine appears effective against coronavirus variant found in Britain - study
The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to results of further lab tests released on Wednesday. Emer McCarthy reports.
UP NEXT
UP NEXT
-
Obesity a driving factor in COVID-19 deaths, global report finds
Reuters
-
Germany to ease COVID-19 curbs, ramp up vaccinations
Reuters
-
Merck to help make Johnson & Johnson's COVID-19 vaccine: White House official
Reuters
-
Merck to help make Johnson & Johnson's COVID-19 vaccine: White House official
Reuters
-
New U.S. COVID-19 cases hit plateau after steep drops
Reuters
-
Global COVID-19 infections up for first time in seven weeks, WHO says
Reuters
-
U.S. downplays possibility of sharing COVID-19 vaccines with Mexico
Reuters
-
J&J COVID-19 vaccine shipping to U.S., but new deliveries hinge on regulators
Reuters
-
More than 20 million in Britain get first COVID-19 vaccine dose
Reuters
-
Fauci urges Americans to get any of the three COVID-19 vaccines available
Reuters
-
Fauci urges Americans to get any of the three COVID-19 vaccines available
Reuters
-
Exclusive: Mexico's president expected to ask Biden to share U.S. vaccines, say sources
Reuters
-
"Things are tenuous," U.S. CDC says as downward trend in COVID-19 cases stalls
Reuters
-
UK to prioritise next stage of COVID-19 vaccines by age, not job
Reuters
-
Advisory panel says FDA should authorize Johnson & Johnson COVID-19 vaccine
Reuters
-
FDA advisory panel to review Johnson & Johnson COVID-19 vaccine with thumbs up expected
Reuters